生物藥學研究所

Keyphrases

1. Atrial Fibrillation 100%
2. Catheter Ablation 76%
3. Hepatocellular Carcinoma 69%
4. Taiwan 63%
5. Polystyrene 60%
6. Apoptosis Induction 59%
7. SHP-1 48%
8. Unsaturated Polyester Resin 48%
9. Nanoparticles 44%
10. Ablation 41%
11. Resin 40%
12. Carbon Nanofibers 37%
13. Sorafenib 36%
14. Atrial Fibrillation Ablation 36%
15. Small Interfering RNA (siRNA) 36%
16. Apoptosis 35%
17. Paroxysmal Atrial Fibrillation 35%
18. Chemotherapy 34%
19. Mold Filling 34%
20. Overexpression 32%
21. Pulmonary Vein Isolation 31%
22. Hepatocellular Carcinoma Cells 30%
23. Persistent Atrial Fibrillation 30%
24. 5-fluorouracil (5-FU) 30%
25. Non-Hodgkin Lymphoma 30%
26. Overall Survival 30%
27. Metastatic Colorectal Cancer (mCRC) 29%
28. Carbon Dioxide 29%
29. Nanoclay 28%
30. Atrial Fibrillation Patient 28%
31. Caenorhabditis Elegans 26%
32. Injection Molding 26%
33. Head-and-neck Squamous Cell Carcinoma (HNSCC) 26%
34. 95% Confidence Interval 26%
35. Tumor 26%
36. CIP2A 26%
37. Zebrafish 26%
38. Acute Myeloid Leukemia 26%
39. Low Temperature 25%
40. Prognostic Factors 25%
41. Colorectal Cancer 25%
42. Ventricular Arrhythmia 25%
43. Nanopaper 24%
44. Polyurethane 24%
45. Risk Factors 24%
46. Gene Expression 24%
47. Knockdown 23%
48. Multivariate Analysis 23%
49. Autophagy 22%
50. Liquid Composite Molding 22%
51. MicroRNA 22%
52. Reaction Kinetics 22%
53. B-cell Lymphoma 2 (Bcl-2) 22%
54. Extracellular Vesicles 22%
55. Liver 22%
56. Resin Transfer Molding 21%
57. Hazard Ratio 21%
58. Mechanical Properties 21%
59. Phosphorylation 21%
60. Sheet Molding Compound 21%
61. Fiber Mats 21%
62. Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) 21%
63. Poly(methyl methacrylate) 21%
64. Non-small Cell Lung Cancer (NSCLC) 20%
65. Glass Transition Temperature 20%
66. Lung Cancer 20%
67. CHA2DS2-VASc Score 19%
68. Cisplatin 19%
69. Structural Reaction Injection Moulding 19%
70. Reaction Injection Molding 19%
71. Leucovorin 19%
72. Free Radicals 18%
73. Signal Transducer 18%
74. Aurora A 18%
75. Hematopoietic Stem Cell Transplantation 18%
76. Lipoplexes 18%
77. Protein Phosphatase 2A (PP2A) 18%
78. Unsaturated Polyester 18%
79. Styrene 18%
80. Protein-protein Interaction 18%
81. Diffuse Large B-cell Lymphoma (DLBCL) 18%
82. Polyester 17%
83. Rituximab 17%
84. Clinical Outcomes 17%
85. Interpenetrating Polymer Network 17%
86. Lipid Nanoparticles 17%
87. Reaction Rate 17%
88. Activator of Transcription 3 17%
89. Antisense Oligonucleotides 17%
90. Leukemia 17%
91. Microfluidics 16%
92. Blowing Agent 16%
93. Electroporation 16%
94. Cytotoxicity 16%
95. Chronic Graft-versus-host Disease (cGVHD) 16%
96. Thymosin 16%
97. Asian Patients 16%
98. Targeted Delivery 16%
99. Viscosity 16%
100. Transcription Factor 16%